1.Endoscopic transmural cyst drainage of pancreatic pseudocyst.
Ho Soon CHOI ; Sung Hee LEE ; Geun Tae PARK ; Dong Soo HAN ; Joon Soo HAHM
Korean Journal of Medicine 2002;63(6):725-726
No abstract available.
Drainage*
;
Pancreatic Pseudocyst*
2.Clinical study on the chronic lymphocytic leukemia.
Dong Ho HAHM ; Jee Sook HAHN ; Yoo Hong MIN ; Sun Ju LEE ; Jong Wha LEE ; Yun Woong KO
Korean Journal of Hematology 1991;26(2):363-372
No abstract available.
Leukemia, Lymphocytic, Chronic, B-Cell*
3.Prevalence of Psychiatric Disorders in Male Homeless.
Bong Jin HAHM ; Dong Woo LEE ; Jung Ho LEE ; Young Min CHOI ; Bong Seog KIM ; Seong Ha HONG ; Seong Jin CHO ; Maeng Je CHO
Journal of Korean Neuropsychiatric Association 2003;42(5):644-653
OBJECTIVES: The prevalence of psychiatric disorders in homeless people is higher than the prevalence in a general population. With the increasing interests in homeless people after the economic crisis in Korea, psychiatrists started to investigate the prevalence of psychiatric disorders in homeless people. This study is to assess the prevalence of psychiatric disorders in homeless men living in a city shelter in Seoul and to compare these results with those of previous epiaemiological studies in Korea of homeless people and abroad. METHODS: Among 960 homeless men living in a city shelter in Seoul, 420 men were selected randomly from December 14 to December 29, 1999. Eight trained interviewer administered the Korean version of Composite International Diagnostic Interview (K-CIDI) to the subjects. The lifetime, one-year, and one-month prevalence of the psychiatric disorders in this study were compared to those of the previous studies of Korean general population and of homeless people abroad. RESULTS: The lifetime, one-year, and one-month prevalence of total psychiatric disorders were 71.7%, 49.8% and 45.0% respectively. The lifetime prevalence of nicotine dependence/withdrawal, alcohol use disorders (abuse/dependence), substance use disorders, major depressive disorder, psychotic disorders, and anxiety disorders were 31.0%, 58.6% (39.3%/19.3%), 3.1%, 11.7%, 2.4%, and 16.9% respectively. CONCLUSION: This study suggested that the prevalence of psychiatric disorders in homeless men is higher than the prevalence in general population, as the previous studies in Korea. The prevalence of alcohol use disorder was highest. The prevalence of non-alcohol substance use disorder and psychotic disorder were lower than the prevalence of these disorders in homeless people of other countries. These results suggest that there is a need to treat the psychiatric disorders, especially alcohol use disorder which is the major psychiatric problem in homeless men.
Anxiety Disorders
;
Depressive Disorder, Major
;
Epidemiology
;
Humans
;
Korea
;
Male*
;
Multiple Endocrine Neoplasia Type 1
;
Nicotine
;
Prevalence*
;
Psychiatry
;
Psychotic Disorders
;
Seoul
;
Substance-Related Disorders
4.Highlights from the 50th Seminar of the Korean Society of Gastrointestinal Endoscopy.
Eun Young KIM ; Il Ju CHOI ; Kwang An KWON ; Ji Kon RYU ; Seok Ho DONG ; Ki Baik HAHM
Clinical Endoscopy 2014;47(4):285-294
The July issue of Clinical Endoscopy deals with selected articles covering the state-of-the-art lectures delivered during the 50th seminar of the Korean Society of Gastrointestinal Endoscopy (KSGE) on March 30, 2014, highlighting educational contents pertaining to either diagnostic or therapeutic gastrointestinal (GI) endoscopy, which contain fundamental and essential points in GI endoscopy. KSGE is very proud of its seminar, which has been presented twice a year for the last 25 years, and hosted more than 3,500 participants at the current meeting. KSGE seminar is positioned as one of premier state-of-the-art seminars for endoscopy, covering topics for novice endoscopists and advanced experts, as well as diagnostic and therapeutic endoscopy. The 50th KSGE seminar consists of more than 20 sessions, including a single special lecture, concurrent sessions for GI endoscopy nurses, and sessions exploring new technologies. Nine articles were selected from these prestigious lectures, and invited for publication in this special issue. This introductory review, prepared by the editors of Clinical Endoscopy, highlights core contents divided into four sessions: upper GI tract, lower GI tract, pancreatobiliary system, and other specialized topic sessions, including live demonstrations and hands-on courses.
Endoscopy
;
Endoscopy, Gastrointestinal*
;
Lectures
;
Lower Gastrointestinal Tract
;
Publications
;
Upper Gastrointestinal Tract
5.Suppression of Helicobacter pylori-induced Angiogenesis by a Gastric Proton Pump Inhibitor.
Sung Ho JIN ; Hwa Young LEE ; Dong Kyu KIM ; Yong Kwan CHO ; Ki Baik HAHM ; Sang Uk HAN
Journal of the Korean Gastric Cancer Association 2005;5(3):191-199
BACKGROUND: Though infections of Helicobacter pylori (H. pylori) are closely associated with activation of host angiogenesis, the underlying mechanisms, as well as the strategy for its prevention, have not been identified. Here, we investigated a causal role of H. pylori infection in angiogenesis of gastric mucosa and a potent inhibitory effect of a gastric proton pump inhibitor (PPI) on the gastropathy. MATERIALS AND METHODS: A comparative analysis of CD 34 expression in tissues obtained from 20 H. pylori-associated gastritis and 18 H. pylori-negative gastritis patients was performed. Expression of HIF-1alpha and VEGF were tested by using RT-PCR. To evaluate the direct effect of H. pylori infection on differentiation of endothelial HUVEC cells, we carried out an in vitro angiogenesis assay. RESULTS: H. pylori-associated gastritis tissues showed significantly higher density of CD34+ blood vessels than did H. pylori-negative gastritis tissues, and the levels were well correlated with expressions of HIF-1alpha. Conditioned media from H. pylori-infected gastric mucosal cells stimulated a tubular formation of HUVEC cells. We also found a significant inhibitory effect of PPI, an agent frequently used for H. pylori eradication, on H. pylori-induced angiogenesis. This drug effectively inhibited the phosphorylation of MAP kinase ERK1/2, which is a principal signal for H. pylori-induced angiogenesis. CONCLUSION: The fact that PPIs can down-regulate H. pylori-induced angiogenesis suggest that anti-angiogenic treatment using PPI may be a preventive approach for H. pylori-associated carcinogenesis.
Blood Vessels
;
Carcinogenesis
;
Culture Media, Conditioned
;
Gastric Mucosa
;
Gastritis
;
Helicobacter pylori
;
Helicobacter*
;
Human Umbilical Vein Endothelial Cells
;
Humans
;
Phosphorylation
;
Phosphotransferases
;
Proton Pumps*
;
Protons*
;
Stomach Neoplasms
;
Vascular Endothelial Growth Factor A
6.Highlights of the 48th Seminar of Korean Society of Gastrointestinal Endoscopy.
Kwang An KWON ; Il Ju CHOI ; Eun Young KIM ; Seok Ho DONG ; Ki Baik HAHM
Clinical Endoscopy 2013;46(3):203-211
This special May issue of Clinical Endoscopy discusses the tutorial contents dealing with either the diagnostic or therapeutic gastrointestinal (GI) endoscopy that contain very fundamental and essential points in this filed. The seminar of Korean Society of Gastrointestinal Endoscopy (KSGE) had positioned as one of prime educational seminars covering the very beginner to advanced experts of GI endoscopy. Besides of four rooms allocated for each lecture, two additional rooms were open for either live demonstration or hands-on course, covering totally 20 sessions including one special lecture. Among these prestigious lectures, 12 lectures were selected for the current review articles in this special issue of Clinical Endoscopy journal. Basic course for beginner to advanced tips to expert were all covered in this seminar. This introductory review prepared by four associated editors of Clinical Endoscopy contained core contents divided into four sessions-upper gut, lower gut, pancreaticobiliary, and specialized topic session part-to enhance understandings not covered by enlisted review articles in this issue.
Endoscopy
;
Endoscopy, Gastrointestinal
;
Lectures
7.Brain MRI Findings of the Olivopontocerebellar Atrophy.
Ki Ho PARK ; Dong Woo PARK ; Jae Cheon OH ; Yong Joo LEE ; Seung Ro LEE ; Chang Kok HAHM
Journal of the Korean Radiological Society 1999;41(4):629-634
PURPOSE: To demonstrate the MRI findings of olivopontocerebellar atrophy. MATERIALS AND METHODS: We retrospectively reviewed the MRI findings of eight patients who had been diagnosed by clinical manifestation and the peculiar pattern of atrophy and signal change on MRI. RESULTS: Seven patients had an atrophy of the olive, pons and cerebellum and increased signal change of the transverse pontine fiber, median raphe and middle cerebellar peduncle on T2WI. Of these, six patients had severe atrophy of the olive, pons and cerebellum and decreased signal change of the basal ganglia, red nucleus, substantia nigra or dentate nucleus on T2WI. Additionally, four of six patients had a cerebral atrophy. Except one patient who had an urinary incontinence, these 5 patients had not been associated with extrapyramidal or autonomic symptom. The other patient with relatively short duration of the disease had only cerebellar atrophy without signal change on T2WI . CONCLUSION: With progressing of the olivopontocerebellar atrophy, cerebral atrophy and decreased signal change of the basal ganglia, red nucleus, substantia nigra or dentate nucleus on T2WI is combined. Thus, MRI is essential in establishing the diagnosis and evaluating the severity of olivopontocerebellar atrophy.
Atrophy
;
Basal Ganglia
;
Brain*
;
Cerebellar Nuclei
;
Cerebellum
;
Diagnosis
;
Humans
;
Magnetic Resonance Imaging*
;
Olea
;
Olivopontocerebellar Atrophies*
;
Pons
;
Red Nucleus
;
Retrospective Studies
;
Substantia Nigra
;
Urinary Incontinence
8.Effects of Brief Symptom Management Module on Inpatients with Chronic Schizophrenia: A Preliminary Study.
Choong Sik CHOI ; Jeong Ho CHAE ; Dong Won WOO ; Young Hee CHOI ; Woong HAHM ; Kyu Hang LEE ; Mi Hwa JANG
Journal of Korean Neuropsychiatric Association 2001;40(1):72-80
OBJECTIVES: The purpose of this study was to examine whether Symptom Management Module-Korean Brief Version(SMM-B) is effective as a psychosocial treatment of the inpatients with chronic schizophrenia. We also questioned which of demographic and clinical characteristics could be predictors of differential treatment response. METHODS: The subjects were composed of 30 inpatients with chronic schizophrenia, who were trained with weekly session of SMM-B for 5 weeks. Before and after the training, the level of psychopathology, knowledge about schizophrenia were assessed as dependent variables by using Clinical Global Impression(CGI) and Scale to Assess Unawareness of Mental Disorder(SUMD). RESULTS: Overall, patients showed improvement over the treatment period on psychopathology as well as knowledge about psychosis. Total scores of SUMD were changed from 16.9+/-4.0 before training to 12.9+/-4.2 after training(p<0.01) and scores of CGI were improved from 3.7+/-0.9 to 2.8+/-0.8 (p<0.01). However age, gender, years of education, age of onset, duration of illness, duration of admission, numbers of psychiatric admission, and clinical status evaluated by CGI were not correlated with un-awareness of psychosis. CONCLUSION: These results suggest that SMM-B could be a reliable method to improve self-awareness of psychosis in patients with chronic schizophrenia and one of important elements in rehabilitation.
Age of Onset
;
Education
;
Humans
;
Inpatients*
;
Psychopathology
;
Psychotic Disorders
;
Rehabilitation
;
Schizophrenia*
9.Three Cases of Hepatitis Related to the Use of Famotidine and Ranitidine.
Joo Hyun SOHN ; Young Woo SOHN ; Yong Cheol JEON ; Dong Soo HAN ; Joon Soo HAHM ; Ho Soon CHOI ; Kyung Nam PARK ; Choon Suhk KEE
The Korean Journal of Hepatology 1998;4(2):194-199
H2-receptor blockers are widely used for therapy of peptic ulcer disease and gastroesophageal reflux disease. H2-receptor blockers infrequently cause adverse hepatic effects, and when they occur they are usually asymptomatic. There are several previous reports of liver injury related to ranitidine. Until now, only two cases of acute hepatitis associated with the use of famotidine were reported in the world. We report three cases of clinical hepatitis that followed administration of famotidine (2 cases) and ranitidine (1 case). First, a 54-year-old woman received famotidine, 40mg, daily for treatment of erosive gastritis. After 6 weeks of treatment with famotidine, jaundice and itching sense developed. Second, a 45-year-old man was hospitalized for jaundice. He had a long history of duodenal ulcer and had been intermittently treated with famotidine. He had 6 weeks of treatment with famotidine prior to admission. Third, a 19-year-old woman was hospitalized for nausea, vomiting and urticaria. She had a history of acute hepatitis B virus infection and was discharged 4 weeks prior to readmission. She had been received ranitidine, 300 mg, daily for treatment of gastritis. After 17 days of drug ingestion, whenever she had taken her medication, she developed these symptoms of nausea, vomiting and urticaria. Other causes of hepatitis were ruled out and all patients recovered after discontinuation of drug ingestion.
Duodenal Ulcer
;
Eating
;
Famotidine*
;
Female
;
Gastritis
;
Gastroesophageal Reflux
;
Hepatitis B virus
;
Hepatitis*
;
Humans
;
Jaundice
;
Liver
;
Middle Aged
;
Nausea
;
Peptic Ulcer
;
Pruritus
;
Ranitidine*
;
Urticaria
;
Vomiting
;
Young Adult
10.Three Cases of Hepatitis Related to the Use of Famotidine and Ranitidine.
Joo Hyun SOHN ; Young Woo SOHN ; Yong Cheol JEON ; Dong Soo HAN ; Joon Soo HAHM ; Ho Soon CHOI ; Kyung Nam PARK ; Choon Suhk KEE
The Korean Journal of Hepatology 1998;4(2):194-199
H2-receptor blockers are widely used for therapy of peptic ulcer disease and gastroesophageal reflux disease. H2-receptor blockers infrequently cause adverse hepatic effects, and when they occur they are usually asymptomatic. There are several previous reports of liver injury related to ranitidine. Until now, only two cases of acute hepatitis associated with the use of famotidine were reported in the world. We report three cases of clinical hepatitis that followed administration of famotidine (2 cases) and ranitidine (1 case). First, a 54-year-old woman received famotidine, 40mg, daily for treatment of erosive gastritis. After 6 weeks of treatment with famotidine, jaundice and itching sense developed. Second, a 45-year-old man was hospitalized for jaundice. He had a long history of duodenal ulcer and had been intermittently treated with famotidine. He had 6 weeks of treatment with famotidine prior to admission. Third, a 19-year-old woman was hospitalized for nausea, vomiting and urticaria. She had a history of acute hepatitis B virus infection and was discharged 4 weeks prior to readmission. She had been received ranitidine, 300 mg, daily for treatment of gastritis. After 17 days of drug ingestion, whenever she had taken her medication, she developed these symptoms of nausea, vomiting and urticaria. Other causes of hepatitis were ruled out and all patients recovered after discontinuation of drug ingestion.
Duodenal Ulcer
;
Eating
;
Famotidine*
;
Female
;
Gastritis
;
Gastroesophageal Reflux
;
Hepatitis B virus
;
Hepatitis*
;
Humans
;
Jaundice
;
Liver
;
Middle Aged
;
Nausea
;
Peptic Ulcer
;
Pruritus
;
Ranitidine*
;
Urticaria
;
Vomiting
;
Young Adult